Clinical Trial Update: Trial of DB289 for the Treatment of Stage I African Trypanosomiasis [Phase 2]

View source ↗

Summary

Phase 2 trial update for DB289 in Stage I African trypanosomiasis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• African Trypanosomiasis

Drugs mentioned

• DB289

Snippet

Sponsor: Immtech Pharmaceuticals, Inc | Conditions: African Trypanosomiasis | Phase 2 | Status: COMPLETED